Innovation Ventures hosts various types of events. Our Seminars are one type of event that occur quarterly and are designed to bring useful and timely information to Cincinnati Children’s Innovators on topics related to intellectual property, commercialization and entrepreneurship.
In the Seminar Series you will have an opportunity to learn and hear from the perspective of Industry, Inventors, and Investors.
May 23, 2019 8:15am Room S5.125
Venture Capital Perspective: Tech-Enabled Investing
Participate in a moderated discussion with a leading technology-driven investor, Harsh Patel, Managing Partner & Co-Founder, Wireframe Ventures. Learn how Venture Capitalists assess a pitch and hear real world anecdotes and examples. Coffee and fruit provided. Please RSVP to Ginny Van Horne at email@example.com by 5/20/19.
May 29, 2019 8:15am Room S3.125
Learn from a Venture Capitalist: Make Your Pitch Stand Out
Participate in an informal coaching session from a leading life science investor, Shinichiro Fuse, PhD, Managing Director, MPM Capital, on how to pitch your discovery/technology in a compelling way. Coffee and fruit provided. Please RSVP to Ginny Van Horne at firstname.lastname@example.org by 5/20/19.
April 19, 2018
Gavi Begtrup, PhD, Chief Executive Officer, Eccrine Systems, Inc
Gavi Begtrup discussed how Eccrine Systems is integrating developments in microfluidics, miniaturized electronics, and electrochemical biosensors to move diagnostics from the lab to the body. Dr. Begtrup discussed Eccrine's first product, a heat stress and dehydration avoidance monitor for the industrial workforce, as well as future applications for non-invasive, continuous monitoring of biomarkers in sweat to improve health across medicine, industry, military, and sports.
April 19, 2017
Joseph Sypek, PhD, Shire
Dr. Sypek and Cincinnati Children's representatives released the 2017 Cincinnati Children's and Shire Research Alliance Request for Proposals (RFP).
May 4, 2017
Mike Bishop, Director, Medicinal Chemistry, Discovery Partnerships with Academia (DPAc), GSK
Dr. Bishop provided an overview of DPAc. Comprised of leading GSK scientists with a broad range of backgrounds across numerous therapeutic areas and drug target classes, the DPAc team evaluates, establishes, and co-leads research programs with leading academia researchers to deliver new medicines - pairing the best of academic with GSK's drug expertise to translate innovative research into medicines.
June 26, 2017
Jan Rosenbaum, PhD, Airway
Jan Rosenbaum and Innovation Ventures representatives discussed the value in drug development and today's investment climate for Biotech companies and how value is defined.
No past events, please refer to our upcoming seminars!
September 19, 2018
Mike Myers, Senior Director, Due Diligence - Lilly Research Labs
Mike Myers provided a perspective on external innovation. Mike shared: Lilly's priorities, understanding the external innovation environment, framing the problem, and Lilly's approach to external innovation.
For any questions or additional information, please contact Michael Pistone.